Frontiers in Oncology | Thoracic Oncology

Clinical Trial

Published on 14 Dec 2022

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

in Thoracic Oncology

Feng Rong
Rui Shi
Lili Hu
Ran Chen
Daoyue Wang
Xiazhi Lv
Yong Zhao
Wei Huang
Yang Yang
Hongyang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1059999

3,451 views
5 citations

Original Research

Published on 14 Dec 2022

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

in Thoracic Oncology

Linlin Zhang
Shasha Guan
Fanlu Meng
Lin Teng
Diansheng Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.1035808

3,623 views
5 citations

Systematic Review

Published on 14 Dec 2022

Current status and challenges of immunotherapy in ALK rearranged NSCLC

in Thoracic Oncology

Rongbin Qi
Yingying Yu
Mo Shen
Dongqing Lv
Susu He

Frontiers in Oncology

doi 10.3389/fonc.2022.1016869

5,079 views
8 citations

Case Report

Published on 14 Dec 2022

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

in Thoracic Oncology

Siqi Zhou
Jianxin Zhang
Xue Meng
Yingtao Meng
Xiao Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1026087

2,491 views
1 citation

Correction

Published on 13 Dec 2022

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

in Thoracic Oncology

Ni Zhao
Ye Yi
Wen Cao
Xiao Fu
Nan Mei
Chunli Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1069999

1,559 views
9 citations

Original Research

Published on 13 Dec 2022

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

in Thoracic Oncology

Hao Wang
Li Liao
Yuan Xu
Yunchun Long
Ye Wang
Yujie Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.1081750

3,510 views
4 citations

Correction

Published on 13 Dec 2022

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

in Thoracic Oncology

Juan Wang
Yixiao Yuan
Lin Tang
Haoqing Zhai
Dahang Zhang
Lincan Duan
Xiulin Jiang
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1109637

1,691 views
9 citations

Editorial

Published on 12 Dec 2022

Editorial: Long non-coding RNAs in lung cancer

in Thoracic Oncology

Umberto Malapelle
Giulia Veronesi

Frontiers in Oncology

doi 10.3389/fonc.2022.1100061

1,265 views

Review

Published on 08 Dec 2022

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management

in Thoracic Oncology

Zhedong Zhang
Lixin Zhou
Fan Yang
Xiao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1011712

7,393 views
7 citations

Original Research

Published on 08 Dec 2022

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit

in Thoracic Oncology

Qiang Miao
Bei Cai
Qian Niu
Junlong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1072531

2,617 views
6 citations

Mini Review

Published on 08 Dec 2022

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer

in Thoracic Oncology

Claudio Martin
Diego Enrico

Frontiers in Oncology

doi 10.3389/fonc.2022.962947

3,698 views
9 citations

Original Research

Published on 08 Dec 2022

The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study

in Thoracic Oncology

Kai Chen
Peiling Dai
Jiangwei Ni
Yili Xiang
Lizhong Gu

Frontiers in Oncology

doi 10.3389/fonc.2022.1050800

2,613 views
6 citations

Case Report

Published on 07 Dec 2022

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

in Thoracic Oncology

Meng-Hang Yang
Jia Yu
Chen-Lei Cai
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1029282

4,420 views
12 citations

Editorial

Published on 02 Dec 2022

Editorial: Insights in thoracic oncology: 2021/2022

in Thoracic Oncology

Kaushal Parikh
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2022.1089540

4,807 views

Original Research

Published on 02 Dec 2022

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma

in Thoracic Oncology

Ronghua Mu
Zhuoni Meng
Zixuan Guo
Xiaoyan Qin
Guangyi Huang
Xuri Yang
Hui Jin
Peng Yang
Meimei Deng
Xiaodi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.868216

3,821 views
13 citations

Case Report

Published on 01 Dec 2022

Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation

in Thoracic Oncology

Yuanpeng Zhai
Yu Shao
Qian Li

Frontiers in Oncology

doi 10.3389/fonc.2022.987484

2,607 views
1 citation

Original Research

Published on 01 Dec 2022

Development and validation a simple scoring system to identify malignant pericardial effusion

in Thoracic Oncology

Xiaxia Jin
Lingling Hu
Meidan Fang
Qiaofei Zheng
Yuan Yuan
Guoguang Lu
Tao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1012664

2,910 views
4 citations

Original Research

Published on 30 Nov 2022

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer

in Thoracic Oncology

Tianyu He
Ziheng Wu
Pinghui Xia
Weidong Wang
Hua Sun
Li Yu
Wang Lv
Jian Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1047019

3,003 views
6 citations

Original Research

Published on 29 Nov 2022

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

in Thoracic Oncology

Lupeng Qiu
Shan Gao
Sicheng Du
Shengjie Sun
Yanjie Liang
Zhuoya Sun
Tao Li
Guhe Jia
Ke Li
Xiaohui Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.974227

2,777 views
3 citations

Systematic Review

Published on 29 Nov 2022

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

in Thoracic Oncology

Jiaqi Li
Yingjie Chen
Fan Hu
Huiping Qiang
Qing Chang
Jialin Qian
Yinchen Shen
Yong Cai
Tianqing Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.1001503

6,140 views
5 citations

Original Research

Published on 29 Nov 2022

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway

in Thoracic Oncology

Siri Børø
Steinar Thoresen
Åslaug Helland

Frontiers in Oncology

doi 10.3389/fonc.2022.1017902

3,733 views
6 citations

Mini Review

Published on 29 Nov 2022

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

in Thoracic Oncology

Alec S. Britt
Caitlyn Huang
Chao H. Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.996554

3,706 views
3 citations

Systematic Review

Published on 28 Nov 2022

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

in Thoracic Oncology

Min Wu
Jun Jiang
Xuewen Zhang
Jie Chen
Qiaomei Chang
Rong Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1024833

3,620 views
3 citations

Case Report

Published on 25 Nov 2022

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy

in Thoracic Oncology

Xiguang Liu
Yating Zheng
Shijie Mai
Yu Tong
Lili Yang
Mengli Huang
Ruijun Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.1033322

3,125 views
3 citations

1,929 articles

articles

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

Current status and challenges of immunotherapy in ALK rearranged NSCLC

Case Report: Bronchial artery embolization and chemoradiotherapy for central squamous cell lung carcinoma with rapid regression

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma

Editorial: Long non-coding RNAs in lung cancer

The natural growth history of persistent pulmonary subsolid nodules: Radiology, genetics, and clinical management

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer

The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

Editorial: Insights in thoracic oncology: 2021/2022

Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma

Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation

Development and validation a simple scoring system to identify malignant pericardial effusion

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy